Please assess the completion status of the following clinical trial:

Trial Title: NeoCart Phase 2 Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients presenting with symptomatic knee pain indicative of an articular cartilage injury and able and willing to give informed consent.~Exclusion Criteria:~* Patients with any previous surgical treatment other than debridement or microfracture of the study cartilage defect.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- NeoCart (Type: EXPERIMENTAL): None
- microfracture (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).